The American College of Radiology and the American Brachytherapy Society practice parameter for the performance of low-dose-rate brachytherapy. Brachytherapy 2017;16(1):68-74
Date
01/23/2017Pubmed ID
28109633DOI
10.1016/j.brachy.2016.06.013Scopus ID
2-s2.0-85009921587 (requires institutional sign-in at Scopus site) 10 CitationsAbstract
Brachytherapy is the use of radionuclides to treat malignancies or benign conditions by means of a radiation source placed close to or into the tumor or treatment site. This practice parameter refers only to the use of radionuclide brachytherapy. Brachytherapy alone or combined with external beam therapy plays an important role in the management and treatment of patients with cancer. Low-dose-rate (LDR) brachytherapy has traditionally been used for treating prostate, head and neck, breast, cervical, and endometrial cancers as well as obstructive bile duct, esophageal, or bronchial lesions. It has been practiced for over a century with a variety of sources including radium-226, cesium-137, and, more recently, iridium- 192, iodine-125, and palladium-103. Low-dose-rate (LDR) brachytherapy can be given as interstitial, intracavitary, intraluminal, and/or plesiotherapy to a wide variety of treatment sites. This practice parameter addresses sealed sources as they are used for LDR brachytherapy. It is recognized that unsealed sources (e.g., yttrium-90) are also a form of LDR brachytherapy.
Author List
Viswanathan AN, Erickson BA, Ibbott GS, Small W Jr, Eifel PJAuthor
Beth A. Erickson MD Professor in the Radiation Oncology department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
Bile Duct NeoplasmsBrachytherapy
Breast Neoplasms
Bronchial Neoplasms
Cesium Radioisotopes
Endometrial Neoplasms
Esophageal Neoplasms
Female
Head and Neck Neoplasms
Humans
Iodine Radioisotopes
Iridium Radioisotopes
Male
Neoplasms
Palladium
Prostatic Neoplasms
Radiation Oncology
Radioisotopes
Radiology
Radiotherapy Dosage
Radium
Societies, Medical
United States
Uterine Cervical Neoplasms
Yttrium Radioisotopes
